Results 101 to 110 of about 92,303 (298)

Phase Engineering of Nanomaterials (PEN): Evolution, Current Challenges, and Future Opportunities

Advanced Materials, EarlyView.
This review summarizes the synthesis, phase transition, advanced characterization spanning ex situ to in situ and operando techniques, and diverse applications of phase engineering of nanomaterials (PEN). It further outlines key challenges and future opportunities, such as phase stability, architecture control, and artificial intelligence (AI)‐driven ...
Ye Chen, Zhanxi Fan, Jingjie Ge, Qiyuan He, Zhuangchai Lai, Jiawei Liu, Chaoliang Tan, Hua Zhang   +7 more
wiley   +1 more source

Quantifying the biodistribution of nanoparticles [PDF]

Nature Nanotechnology, 2011
Xiao, He, Zhiyong, Zhang, Jinsen, Liu, Yuhui, Ma, Peng, Zhang, Yuanyuan, Li, Zhenqiang, Wu, Yuliang, Zhao, Zhifang, Chai   +8 more
openaire   +4 more sources

Development of 111In-labeled porphyrins for SPECT imaging [PDF]

Asia Oceania Journal of Nuclear Medicine and Biology, 2014
Objectives: The aim of this research was the development of 111In-labeled porphyrins as possible radiopharmaceuticals for the imaging of tumors. Methods: Ligands, 5, 10, 15, 20-tetrakis (3, 5-dihydroxyphenyl) porphyrin) (TDHPP), 5, 10, 15, 20-tetrakis (4-
Shaghayegh Sadeghi, Mohammad Mirzaei, Mohammad Rahimi, Amir Jalilian   +3 more
doaj  

Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells

, 2012
Huan Xie1, Beth Goins2, Ande Bao2, Zheng Jim Wang3, William T Phillips21Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, 2Department of Radiology, University of Texas Health Science ...
Xie H, Goins B, Phillips WT, Wang ZJ, Bao A   +4 more
core  

Hig biodistribution and amyloid∶organ ratio.

, 2013
Hig biodistribution and amyloid∶organ ratio.
Ying Huang (53474), Sallie Macy (292365), Angela Williams (292362), Jonathan S. Wall (287997), Dale Schenk (222959), Stephen J. Kennel (288001), Tina Richey (292363), Alan Stuckey (292364), Robert Donnell (292366), Peter Seubert (222943), Robin Barbour (222950)   +10 more
core   +1 more source

A Chemical Framework for Engineering Extracellular Vesicles’ Biointerface to Advance Precision Therapeutics

Advanced Materials, EarlyView.
Extracellular vesicles (EVs) are cell‐derived nanoparticles that mediate intercellular communication through their dynamic biointerfaces. Owing to their intrinsic biological functions, EVs have emerged as promising platforms for biomedical applications.
Leila Pourtalebi Jahromi, Felix Geng, Jan‐Noël Frenzke, Gregor Fuhrmann   +3 more
wiley   +1 more source

The impact of PEGylation patterns on the in vivo biodistribution of mixed shell micelles

, 2013
Hongjun Gao,2# Jinjian Liu,1# Cuihong Yang,1 Tangjian Cheng,2 Liping Chu,1 Hongyan Xu,1 Aimin Meng,1 Saijun Fan,1 Linqi Shi,2 Jianfeng Liu11Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine ...
Cheng T, Liu J, Shi L, Meng A, Gao H, Xu H, Yang C, Chu L, Fan S   +8 more
core  

Shi biodistribution and amyloid∶organ ratio.

, 2013
Shi biodistribution and amyloid∶organ ratio.
Ying Huang (53474), Sallie Macy (292365), Angela Williams (292362), Jonathan S. Wall (287997), Dale Schenk (222959), Stephen J. Kennel (288001), Tina Richey (292363), Alan Stuckey (292364), Robert Donnell (292366), Peter Seubert (222943), Robin Barbour (222950)   +10 more
core   +1 more source

Ionizable Lipid‐Dependent Optimization of Steroid Lipid Nanoparticles With Tunable Immunomodulatory Properties

Advanced Materials, EarlyView.
A novel engineering strategy that establishes material design principles for incorporating anti‐inflammatory steroids into lipid nanoparticles to reduce LNP‐induced inflammation while retaining mRNA delivery. Results are validated in vitro and in three animal models of inflammation and autoimmunity in vivo.
Ajay S. Thatte, Benjamin E. Nachod, Julia Baena, Jenna Muscat‐Rivera, Lesley Chaboub, Hannah C. Safford, Hannah C. Geisler, Hannah M. Yamagata, Melgious J. Y. Ang, Michael Kegel, Alexandre Poirier, Elaine R. Tong, Zhe Zhong, Qiangqiang Shi, Jinjin Wang, Elisa Battistini, Ye Zeng, Alex G. Hamilton, Kelsey L. Swingle, Drew Weissman, Jilian R. Melamed, Michael J. Mitchell   +21 more
wiley   +1 more source

Anisotropic Masked Mycobacterium Potentiates Amplified Antitumor Trained Immunity via Spleen Targeting and Myelopoiesis Conversion

Advanced Materials, EarlyView.
An engineered Trojan Mycobacterium, developed via a “peeling‐off and masking‐up” strategy, functions as a powerful splenic myelopoiesis converter. This spleen‐targeted nanomedicine induces trained immunity to reprogram immunosuppressive myeloid reservoirs into antitumoral effectors.
Jin‐Ho Choi, Sang Nam Lee, Jang Hun Heo, Soyoung Park, Sei Hyun Park, Yong Taik Lim   +5 more
wiley   +1 more source